7,8,10-Trimethylbenzo[g]pteridine-2,4(3H,10H)-dione

Catalog No. :
ACCMOR073
CAS No. :
1088-56-8
Molecular Formula :
C13H12N4O2
Molecular Weight :
256.27

IUPAC Name:7,8,10-trimethylbenzo[g]pteridine-2,4(3H,10H)-dione

7,8,10-Trimethylbenzo[g]pteridine-2,4(3H,10H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg97%$104.00Login to see priceIn stockInquiry
50mg97%$189.00Login to see priceIn stockInquiry
100mg97%$312.00Login to see priceIn stockInquiry
250mg97%$529.00Login to see priceIn stockInquiry
1g97%$1956.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7,8,10-Trimethylbenzo[g]pteridine-2,4(3H,10H)-dione
IUPAC Name7,8,10-trimethylbenzo[g]pteridine-2,4(3H,10H)-dione
MDL No.0
Molecular FormulaC13H12N4O2
Molecular Weight256.27
SMILESO=C(N1)N=C2N(C)C3=CC(C)=C(C)C=C3N=C2C1=O
InChI KeyKPDQZGKJTJRBGU-UHFFFAOYSA-N
Synonym7,8,10-trimethyl-2H,3H,4H,10H-benzo[g]pteridine-2,4-dione | 7,8,10-Trimethylbenzo(g)pteridine-2,4,(3H,10H)-dione | BENZO(G)PTERIDIN-2(10H)-ONE, 4-HYDROXY-7,8,10-TRIMETHYL- | AKOS004910107 | KPDQZGKJTJRBGU-UHFFFAOYSA- | LUMIFLAVINE [MI] | RIBOFLAVIN SODIUM
CAS No.1088-56-8
PubChem CID66184

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACCMOR073 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCMOR073 route product structure diagram
    ACCMOR0731088-56-8 In Stock
Inquiry

2. ACCMOR073 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCMOR073 route product structure diagram
    ACCMOR0731088-56-8 In Stock
Inquiry

Comments (0)